the neurotoxicology of attention deficits: dietary manganese exposure as a particular case sabrina...
TRANSCRIPT
The Neurotoxicology of attention deficits: Dietary Manganese Exposure as a
Particular Case
Sabrina E.B. Schuck, Ph.D., Melody Yi, Ph.D. & Francis M. Crinella, Ph.D.
The Child Development CenterUniversity of California, Irvine
Everyone knows what attention is. It is the taking possession in the mind, in clear and vivid form, of one out of what seem several simultaneous object or trains of thought.
William James [The Principles of Psychology, 1890]
ATTENTION HELPS US TO MANAGE CONFLICTING PERCEPTUAL INPUTS
ATTENTION ENABLES US TO PERFORM TASKS THAT REQUIRE PLANNING AND
WORKING MEMORY
HOWEVER: ATTENTION IS THE MOST FRAGILE OF ALL MENTAL FUNCTIONS
1. ATTENTION CAN BE ADVERSELY AFFECTED BY ANY NUMBER OF INTERNAL AND EXTERNAL INFLUENCES
2. ALL NEURODEVELOPMENTAL AND NEUROPSYCHIATRIC DISORDERS ARE ACCOMPANIED BY ATTENTION DEFICITS
3. ADHD IS BUT ONE OF MANY DIAGNOSABLE CONDITIONS IN WHICH ATTENTION IS AFFECTED
DSM-IV SYMPTOMS OF ADHD
INATTENTION
• CAN’T ATTEND TO DETAILS• CAN’T SUSTAIN ATTENTION• DOESN’T LISTEN• FAILS TO FINISH• CAN’T ORGANIZE TASKS• AVOIDS SCHOOLWORK• LOSES THINGS• EASILY DISTRACTED• FORGETFUL
HYPERACTIVITY/IMPULSIVITY
• FIDGETS• CAN’T STAY SEATED• RUN ABOUT AND CLIMBS• CAN’T PLAY QUIETLY• IS OFTEN ON THE GO• TALKS TOO MUCH• BLURTS OUT ANSWERS• CAN’T WAIT TURN• INTERRUPTS OR INTRUDES
BIOLOGICAL BASIS OF ADHD
I. PSYCHOPHARMACOLOGY
II. MOLECULAR BIOLOGY
III.BRAIN IMAGING
IV.ELECTROPHYSIOLOGY
V. NEUROPSYCHOLOGY
I. PSYCHOPHARMACOLOGY
TREATMENT WITH CNS STIMULANTS
BENZEDRINE (Bradley, 1937)
DEXTROAMPHETAMINES (e.g., Dexedrine, Adderall)
METHYLPHENIDATES (e.g., Ritalin, Concerta)
THE DOPAMINE HYPOTHESIS
Wender P. Minimal brain dysfunction in children. Wiley-Liss, New York (1971).
Levy F. The dopamine theory of attention deficit hyperactivity disorder (ADHD). Aust. N. Z. J. Psychiatry 25, 277-83 (1991).
Grady D, Moyzis R, Swanson JM. Molecular genetics and attention in ADHD. Clin. Neurosci. Res. 5, 265-272 (2005).
BIOLOGICAL BASIS OF ADHD II: MOLECULAR BIOLOGY
• DOPAMINE D4 RECEPTOR GENE POLYMORPHISM ASSOCIATED WITH ADHD (Lahoste, Swanson et al., 1996, Molecular Psychiatry)
• ASSOCIATION OF THE DOPAMINE RECEPTOR D4 (DRD4) GENE WITH A REFINED PHENOTYPE OF ADHD (Swanson, Sunohara, Kennedy et al., 1998, Molecular Psychiatry)
• MOLECULAR GENETICS AND ATTENTION IN ADHD (Grady, Moyzis & Swanson, 2005, Clinical Neuroscience Research)
BIOLOGICAL BASIS OF ADHD III: STRUCTURAL
IMAGING
LONGITUDINAL MAPPING OF CORTICAL THICKNESS AND CLINICAL OUTCOME IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER. Shaw, Lerch, Greenstein et al. (2006), Archives of Genetic Psychiatry, 63, 540-549.
IV. ELECTROPHYSIOLOGYEarly studies of analog EEG:
Satterfield, J.H., & Schell, A.M. (1984). Childhood brain function differences in delinquent and non-delinquent hyperactive boys. Electroencephalography and Clinical Neurophysiology, 57, 199-207.
Finding: Abnormal maturational effects of auditory event- related potential differentiated ADHD from non-ADHD subjects
Recent brain mapping studies:
Pliszka, S.R., Liotti, M., & Woldorff, M.G. (2000). Inhibitory control in children with attention-deficit/hyperactivity disorder. Biological Psychiatry, 48,238-46.
Finding: Event related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism.
V: NEUROPSYCHOLOGICAL EVIDENCE
• ADHD conceptualized as “frontal lobe” disorder (e.g., Douglas, 1980; Chelune et al., 1986)
• ADHD conceptualized as disorder of “executive function” (Pennington et al., 1990; Barkley 1997; Schuck & Crinella, 2000)
Brief Definitions of Executive Function
• Appropriate set maintenance to achieve a future goal (Pennington, Welsh & Grossier, 1990)
• A process that alters the probability of subsequent responses to an event, thereby altering the probability of later consequences (Barkley, 1997).
• A process which enables the brain to function as many machines in one, setting and resetting itself dozens of times in the course of a day, now for one type of operation, now for another (Sperry, 1955)
EXECUTIVE FUNCTIONS CAN BE ADVERSELY AFFECTED BY ANY
NUMBER OF NEUROTOXINS
FOR EXAMPLE:
• PESTICIDES
• LEAD (Pb)
• CNS STIMULANTS
Odds Ratio of Detectable Pesticide in SerumChildren 8-12 Years Old (n = 167)
Oahu vs. Neighbor Islands
3.8
1.7
1.01.4
0
1
2
3
4
5
HeptachlorEpoxide
pp'-DDE Oxychlordane trans-Nonachlor
From Baker, Yang & Crinella, 2004, Neurotoxicology, 25, 700-701
STANDARD SCORES ON NEUROBEHAVIORAL TESTS FOR SUBJECTS BORN ON OAHU (n = 332) vs.
SUBJECTS BORN ELSEWHERE (n = 112)
STUDIES ASSOCIATING HAIR MANGANESE [Mn] LEVELS WITH ADHD
Pihl, R.O. & Parks, M. (1977). Hair element content in learning disabled children. Science, 198, 204-206.
Collip, P.J., Chen, S.Y. & Maitinsky, S. (1983). Manganese in infant formulas and learning disability. Annals of Nutrition and Metabolism, 27, 488-494.
Marlowe, M. & Bliss, L. (1993). Hair element concentrations and young children's behavior at school and home. Journal of Orthomolecular Medicine, 9, 1-12.
Cordova, E.J., Ericson, J., Swanson, J.M., & Crinella, F.M. (1997). Head hair manganese as a biomarker for ADHD. Proceedings of the 15th Annual Conference on Neurotoxicology.
IS MN EXPOSURE AN ETIOLOGIC AGENT IN ADHD?
1. CHILDREN WITH ADHD HAVE HIGH LEVELS OF HEAD HAIR MN
2. MN IS A KNOWN NEUROTOXIN
3. MN TOXICITY AFFECTS BRAIN DOPAMINE SYSTEMS
4. ADHD IS A PRIMARILY DOPAMINERGIC DISORDER
Critical Observations Regarding Mn in infants and children
Manganese in head hair of children with ADHD may be the result of soy-based infant formulas (Collip et al., 1983)
Term infants fed soy formula have significantly higher blood Mn than breast-fed infants (Kirchgessner et al., 1981)
High, positive retention of Mn from formula, but not breast milk in preterm infants (Lonnerdal, 1994)
HYPOTHESES
Since Mn is well absorbed from infant diets, and absorbed Mn is retained by the body, it will accumulate in brain, resulting in:
1. Depleted striatal DA
2. Neuromotor delay
3. Executive function deficits
an
Other measurements Hb and Wt
Control (0)50 µg Mn/d250 µg Mn/d500 µg Mn/d
Tissue Mn Assays
d1 d6 d10 d14 d20 d35 d58 d60
Passive Avoidance (60-64)
Digging latencyrunning time (d58)
Passive Avoidance(d35)Righting
(d6) Homing(d10)
Concentrations of Mn in brain of rats killed at day 14, 21 and 35
Brain
0
1
2
3
4
d14 d21 d35
0250500
Striatal Dopamine in Animals Killed at d35
0
10
20
30
0 50 250 500
Mn dose (ug/day)
DA
(n
g/1
0 m
g w
et
tiss
ue)
*Significant difference between control and low Mn exposure
**
Results of Passive Avoidance Test at d32
control 50 ug 250 ug 500 ug0.0
2.5
5.0
7.5
Mn (ug/day)
No
. o
f F
oo
tsh
ock
s
Results of Burrowing Detour Test d55
Digging Latency
Control 50 250 5000
100
200
300
400
500
Mn (g/day)
Tim
e (
sec)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
0 50 250 500
TREATMENT LEVEL (ug/l)
DA
LE
VE
L (n
g/m
g)STRIATAL DOPAMINE LEVELS AT d65
NONHUMAN PRIMATE MODELS
ADVANTAGES OVER RODENT MODEL– Maturity of brain development at birth– Prolonged period of postnatal brain
development– Complexity of behavioral repertoire– Assessments similar to humans
Study Design
• Subjects: Male newborn rhesus monkeys
• Treatment: Exclusively formula fed freom 0-4 months of age
• Groups (n = 8): Cow’s milk based infant formula, 0.03 µg
Mn /ml Soy based infant formula, 0.3 µg Mn/ml Soy + Mn; soy based infant formula with
added manganese, 1 µg Mn/ml
Behavior testing schedule APOMORPHINE DRUG CHALLENGE
NON-MATCH TO SAMPLE
POSITION REVERSAL
DIURNAL ACTIVITY
MOTOR MATURATION
IMPULSIVITY TESTS:
CPT
FORMULA FEEDING
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Gross Motor Maturation
02468
10 12 14 16 18 20
0
5
10
15
20
25
30
0
2
4
6
8
10
0
2
4
6
8
10
12
14
02468
10 12 14 16 18 20
0
1
2
3
4
5
Walk
Climb
Manual
1 2 3 4 5 6 7 8 9 10 11 12
Session
Soy + Mn
Soy
Control
Amount of activity
0
20
40
60
80
100
120
Num
ber
of c
ount
s/ 2
min
0
2
4
6
8
10
12
14
4 months 8 months
SLEEP
WAKE
Soy + Mn
Soy
Cow’s milk
*.01
Delayed nonmatch to sample
0
.02
.04
.06
.08
.1
.12
Per
cent
Balks-no sample choice made
.
.
.
.
.
Soy + Mn
Soy
Cow’s milk
Test board 1
Test board 2
Position reversals
0
1
2
3
4
5
6
7
8
Sess
ions
Test board
sessions to criterion for learning
6Soy + Mn
Soy
Cow’s milk
*.05
Impulsivity-response inhibition
0
2.5
5
7.5
10
12.5
15
17.5
20
22.5
25
num
ber
of
tria
ls
*.04
*.03
0 1-6 7 balk interval
average number of trials (of 40) on which the monkey responded at each interval
Soy + Mn
Soy
Cow’s milk
Dopamine drug challenge
-150
-125
-100
-75
-50
-25
0
25
50
75
100
Cha
nge
in r
espo
nse
rate
fro
m v
ehic
le in
ject
ion
0.1 mg/kg
0.2 mg/kg .0.3 mg/kg
-------apomorphine-----
*.01
*.02haloperidol haloperidol+
apomorphine
amphetamine
apomorphine, dopamine agonist, response ratehaloperidol, dopamine antagonist, response rate
Fixed interval responding
Soy + Mn
Soy
Cow’s milk
Social Interaction Study
• Method-videotape of dyadic interaction
• Familiar same group, unfamiliar same group, unfamiliar opposite group
• Social buffering
• Used previously to compare field cage with nursery reared males
0
5
10
15
20
25
30
35
40
num
ber
of o
ccur
renc
es
Chase play Rough play cling
Soy+Mn
Soy
control
dyadic interactions during round robin socialization (16 sessions)
*.003
*.01
*.003
*.003
.06
*.03
Age and formula effects onCSF catecholamine metabolites
0
20
40
60
80
100
120
140
160
Cel
l Mea
n
hi mn
low mn
control
0
50
100
150
200
250
300
350
400
450
500
Cel
l Mea
n
5HIAA HVA
3 10 12 3 10 12
Months of age
Relationship between CSF catecholamine metabolites and impulsivity
51015202530354045
10 20 30 40 50 60 70 80 90 100
R2 = 0.156
5HIAA- 10 months of age
51015202530354045
Ear
ly re
spon
ses
150 200 250 300 350 400 450 500 550
R2 = 0.19
HVA- 10 months of age
THE “TOOTH FAIRY” STUDY
• Participants: 27 children (11 boys) from the NICHD Study of Early Child Care and Youth Development
• Procedures:•
– Shed molars collected from 400 children (ages 11-13); 27 teeth randomly selected
– Measures of children’s behavioral disinhibition collected from ages 3 to 9 years.
– IMS analyses of teeth performed by CAMECA IMS 1270
– Concentration of manganese in the molar cusp tip (formed at approximately the 20th gestational week) used as an indication of prenatal Mn absorption
Tooth Enamel Biomarker
• Tooth enamel layers, like tree rings, provide a temporal record of mineral absorption
• Absorbed minerals, as reflected in the tooth enamel record, may be associated with embryogenetic variations
• Depending on corresponding embryological developments in CNS, Mn absorption, as reflected in tooth enamel record, may be associated with specific variation in behavioral outcomes
Human Tooth Enamel
• As tooth develops over rime, incremental growth rings of enamel are deposited
• Oldest enamel is found at the incisal tip
• Mature enamel is a metabolic isolate
• Mn is stable in calcium hydroxyapatite
Analytical Measurements
• ion microprobe mass spectrometer (ims)• 10 - 35 um spot resolution• auger & sputter sample• measurement of Mn concentration• detection <30 ppb• 90% accuracy
Behavior Battery
• Data base of NICHD Early Childhood Study
• Administered Age 3, Grade 1 and Grade 3• Teachers, mothers, and standardize tests
of subjects• 21 behavior measures (disinhibition,
intelligence and depression) over 5 years• Same subjects maintain position
RESULTSMn LEVELS WERE POSITIVELY CORRELATED
WITH:
Increased play with “Forbidden Toy” (36 mo.)
More impulsive errors on CPT (54 mo.)
More impulsive errors on Stroop Test (54 mo.)
Higher ratings on externalizing behavior and attentional problems (teachers and mothers; 1st and 3rd grades)
Higher incidence of disruptive disorders (ADHD, hyperactivity/impulsivity, and inattention (teachers, 1st and 3rd grades)
MULTIPLE REGRESSION ANALYSIS
(Predicting Mn Level With Behavioral Measures)
CPT (54 months)
Stroop (54 months)
CBCL Inattention (1st grade)
DBD3 HYPERACTIVITY (3RD GRADE)
R2 = 0.62; df = 4, 26; P < .001
Adjustment for socioeconomic confounds did not increase significance
• Mother’s education
• Income
• Ethnicity
(F of change = .13, p = .97)
DISCUSSION• A link was demonstrated between prenatal Mn
absorption and measures of behavioral disinhibition in later childhood
• The source of Mn was unknown, but may have been due to maternal gestational anemia, a common occurrence during pregnancy that results in overabsorption of Mn.
CONCLUSIONS• Attention deficits are observed in almost all neuropsychiatric
disorders, including ADHD
• ADHD symptoms may are associated with a number of genetic, epigenetic and environmental influences, including toxic exposures
• Mn serves as an example of a toxic exposure that can produce ADHD-like symptoms in rodents, non-human primates, and humans
• The Mn-ADHD link is likely to be mediated by toxic effects on DRD4 and DAT genes.
CONCLUSIONS (CONT’D)• The Mn-ADHD link is likely to be mediated by toxic effects on DRD4
and DAT genes.
• A DAT1 40bp VNTR 9/10 polymorphism was reliably associated with greater symptoms of ADHD. Barkley, Smith, Fischer & Bradford, (2006), American Journal of Medical Genetics. 141B, 487-498.
• And, there is persistent evidence that DAT can be adversely impacted by Mn. Kern, Stanwood & Smith, (2010), Synapse, 64, 363-378.
CONTRIBUTORS University of California, Irvine
Aleksandra Chicz-DeMetLouis LeMike ParkerJonathon E. EricsonK. Alison Clarke-StewartVirginia D. AllhusenTony ChanRichard T. Robertson
University of California, DavisBo LonnerdalMari GolubWinyoo ChowanadisaiStacey GermannCasey Hogrefe
University of California, San FranciscoTrinh Tran
City University of New YorkJoey Trampush